Literature DB >> 16118792

Estrogen alters trkA and p75 neurotrophin receptor expression within sympathetic neurons.

Wohaib Hasan1, H Jesse Smith, Alison Y Ting, Peter G Smith.   

Abstract

Survival and growth of sympathetic neurons is regulated by nerve growth factor acting through trkA and p75NTR receptors. Sympathetic neurons are also affected by gonadal steroid hormones, particularly estrogen. To determine if estrogen may influence sympathetic neurons via altered neurotrophin receptor expression, we investigated effects of acute or chronic estrogen administration on levels of trkA and p75NTR proteins, numbers of immunoreactive neurons, and numbers of neurons expressing trkA, p75NTR, and estrogen receptor-alpha transcripts. Superior cervical ganglia from ovariectomized or estradiol-treated rats were processed for in situ hybridization or immunohistochemistry, and percentages of stained neurons quantitated or processed for Western blot analysis. In ovariectomized rats, approximately 50% of sympathetic neurons expressed trkA mRNA and protein. Acute estrogen administration did not affect trkA transcript expression, but reduced trkA protein significantly. Chronic treatment did not alter neuronal trkA expression. Approximately 70% of sympathetic neurons in ovariectomized rats expressed p75NTR transcripts and about 50% showed p75NTR immunoreactivity. Acute estrogen did not affect p75NTR expression. However, chronic estrogen reduced p75NTR mRNA and protein expression significantly. Fifty to sixty percent of sympathetic neurons in ovariectomized rats displayed estrogen receptor-alpha mRNA. After acute estrogen administration, estrogen receptor-alpha transcript expression increased by 35%, although this was not maintained chronically. These findings indicate that estrogen can influence sympathetic neuronal neurotrophin receptor expression as well as estrogen receptor-alpha. Reduced trkA expression after acute estrogen may transiently predispose neurons to degenerative events, while diminished p75NTR expression by chronic estrogen administration may exert long-term effects on survival or axonal outgrowth in sympathetic neurons. (c) 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16118792     DOI: 10.1002/neu.20183

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  8 in total

Review 1.  Estrogen and female reproductive tract innervation: cellular and molecular mechanisms of autonomic neuroplasticity.

Authors:  M Mónica Brauer; Peter G Smith
Journal:  Auton Neurosci       Date:  2014-11-28       Impact factor: 3.145

2.  The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease.

Authors:  Claudius Mueller; Weidong Zhou; Amy Vanmeter; Michael Heiby; Shino Magaki; Mark M Ross; Virginia Espina; Matthew Schrag; Cindy Dickson; Lance A Liotta; Wolff M Kirsch
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 3.  The peritoneum--an important factor for pathogenesis and pain generation in endometriosis.

Authors:  Maria-Luisa Barcena de Arellano; Sylvia Mechsner
Journal:  J Mol Med (Berl)       Date:  2014-03-05       Impact factor: 4.599

4.  Modulation of rat parasympathetic cardiac ganglion phenotype and NGF synthesis by adrenergic nerves.

Authors:  Wohaib Hasan; Peter G Smith
Journal:  Auton Neurosci       Date:  2008-11-18       Impact factor: 3.145

5.  17β-estradiol delays 6-OHDA-induced apoptosis by acting on Nur77 translocation from the nucleus to the cytoplasm.

Authors:  Justine Renaud; Keith Chiasson; Julie Bournival; Claude Rouillard; Maria-Grazia Martinoli
Journal:  Neurotox Res       Date:  2013-11-26       Impact factor: 3.911

6.  Long-term treatment with testosterone alters ovary innervation in adult pigs.

Authors:  Barbara Jana; Karolina A Meller; Michał Bulc; Jarosław Całka
Journal:  J Ovarian Res       Date:  2016-10-10       Impact factor: 4.234

Review 7.  Neuroimmunomodulation by estrogen in health and disease.

Authors:  Hannah P Priyanka; Rahul S Nair
Journal:  AIMS Neurosci       Date:  2020-10-30

8.  MYCN-amplified neuroblastoma maintains an aggressive and undifferentiated phenotype by deregulation of estrogen and NGF signaling.

Authors:  Johanna Dzieran; Aida Rodriguez Garcia; Ulrica Kristina Westermark; Aine Brigette Henley; Elena Eyre Sánchez; Catarina Träger; Henrik Johan Johansson; Janne Lehtiö; Marie Arsenian-Henriksson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-26       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.